Publications

Detailed Information

Prevalence and risk factors of osteoporosis in Korea: A community-based cohort study with lumbar spine and hip bone mineral density

DC Field Value Language
dc.contributor.authorShin, Chan Soo-
dc.contributor.authorChoi, Hyung Jin-
dc.contributor.authorKim, Min Joo-
dc.contributor.authorKim, Jin Taek-
dc.contributor.authorKoo, Bo Kyeong-
dc.contributor.authorCho, Sun Wook-
dc.contributor.authorPark, Young Joo-
dc.contributor.authorKim, Seong Yeon-
dc.contributor.authorCho, Nam H.-
dc.contributor.authorJang, Hak Chul-
dc.contributor.authorKim, Sang Wan-
dc.contributor.authorCho, Hwa Young-
dc.contributor.authorYu, Sung Hoon-
dc.date.accessioned2012-05-25T05:17:06Z-
dc.date.available2012-05-25T05:17:06Z-
dc.date.issued2010-08-
dc.identifier.citationBONE; Vol.47 2; 378-387ko_KR
dc.identifier.issn8756-3282-
dc.identifier.urihttps://hdl.handle.net/10371/76465-
dc.description.abstractPurpose: To investigate bone mineral density (BMD) profiles, osteoporosis prevalence and risk factors in a community-based cohort in Korea. Methods: The present study is a cross-sectional study. The study population consisted of 1,547 men and 1991 women aged 40 years and older with BMD measurements using central dual energy X-ray absorptiometry from a prospective community-based cohort. The data were compared with other ethnic groups. Risk factors related to osteoporosis were analyzed. Results: Crude prevalence of osteoporosis in the whole subjects (40-79 years old) was 13.1% for men and 24.3% for women by WHO criteria, at any site among lumbar spine, femoral neck or total hip. Standardized prevalence of osteoporosis between age of 50 and 79 at lumbar spine, femoral neck and total hip was 12.9%, 1.3% and 0.7% in men and 24.0%, 5.7% and 5.6% in women, respectively. The mean BMD of studied female subjects after age of 50 was not significantly different from that of Chinese but significantly lower than that of Japanese, non-Hispanic whites, non-Hispanic blacks and Mexican Americans. Risk of osteoporosis was significantly associated with the presence of past fracture history (OR, 1.45; 95% CI, 1.08-1.94), smoking >= 1 pack/day (OR, 1.63; 95% CI, 1.01-2.62), menarche after age of 16 (OR, 1.46; 95% CI, 1.14-1.87), last delivery after age of 30 (OR, 1.58; 95% CI, 1.20-2.09), more than three offspring (OR, 1.42; 95% CI, 1.07-1.89), post-menopause status (OR, 7.32; 95% CI, 3.05-17.6), more than 17 years since menopause (OR, 1.53; 95% CI, 1.10-2.14), regular exercise of two to three times per week (OR, 0.40; 95% CI, 0.18-0.89), monthly income above 500,000 won per household (OR, 0.64; 95% CI, 0.45-0.92), college graduate (OR, 0.29; 95% CI, 0.13-0.63) and calcium intake 627.5 mg/day (OR, 0.65; 95% CI, 0.43-0.98) after adjusting for age and BMI. Conclusion: The BMD and osteoporosis prevalence of Koreans are presented. Risk of osteoporosis was significantly associated with fracture history, smoking, reproductive history, regular exercise, income level, education background and calcium intake. (C) 2010 Elsevier Inc. All rights reserved.ko_KR
dc.language.isoenko_KR
dc.publisherELSEVIER SCIENCE INCko_KR
dc.subjectOsteoporosisko_KR
dc.subjectPrevalenceko_KR
dc.subjectDXAko_KR
dc.subjectOsteopeniako_KR
dc.titlePrevalence and risk factors of osteoporosis in Korea: A community-based cohort study with lumbar spine and hip bone mineral densityko_KR
dc.typeArticleko_KR
dc.contributor.AlternativeAuthor신찬수-
dc.contributor.AlternativeAuthor최형진-
dc.contributor.AlternativeAuthor김민주-
dc.contributor.AlternativeAuthor김진택-
dc.contributor.AlternativeAuthor유성훈-
dc.contributor.AlternativeAuthor구보경-
dc.contributor.AlternativeAuthor조화영-
dc.contributor.AlternativeAuthor조선욱-
dc.contributor.AlternativeAuthor김상완-
dc.contributor.AlternativeAuthor박영주-
dc.contributor.AlternativeAuthor장학철-
dc.contributor.AlternativeAuthor김성연-
dc.identifier.doi10.1016/j.bone.2010.03.017-
dc.citation.journaltitleBONE-
dc.description.citedreferenceVenkat KK, 2009, BONE, V45, P449, DOI 10.1016/j.bone.2009.05.005-
dc.description.citedreferenceEmaus N, 2009, EUR J EPIDEMIOL, V24, P321, DOI 10.1007/s10654-009-9333-z-
dc.description.citedreferencePapaioannou A, 2009, OSTEOPOROSIS INT, V20, P507, DOI 10.1007/s00198-008-0720-1-
dc.description.citedreferenceNavarro MC, 2009, OSTEOPOROSIS INT, V20, P393, DOI 10.1007/s00198-008-0697-9-
dc.description.citedreferenceWaugh EJ, 2009, OSTEOPOROSIS INT, V20, P1, DOI 10.1007/s00198-008-0643-x-
dc.description.citedreferenceLewiecki EM, 2008, BONE, V43, P1115, DOI 10.1016/j.bone.2008.08.106-
dc.description.citedreferenceAmiri M, 2008, INT J PUBLIC HEALTH, V53, P290, DOI 10.1007/s00038-008-8033-x-
dc.description.citedreferenceCui LH, 2008, J BONE MINER METAB, V26, P609, DOI 10.1007/s00774-007-0847-8-
dc.description.citedreferenceChevalley T, 2008, J CLIN ENDOCR METAB, V93, P2594, DOI 10.1210/jc.2007-2644-
dc.description.citedreferenceRibom EL, 2008, J CLIN DENSITOM, V11, P404, DOI 10.1016/j.jocd.2007.12.014-
dc.description.citedreferenceKanis JA, 2008, BONE, V42, P467, DOI 10.1016/j.bone.2007.11.001-
dc.description.citedreferenceAhn Y, 2007, EUR J CLIN NUTR, V61, P1435, DOI 10.1038/sj.ejcn.1602657-
dc.description.citedreferenceAllali F, 2007, MATURITAS, V57, P392, DOI 10.1016/j.maturitas.2007.04.006-
dc.description.citedreferenceLau EMC, 2006, OSTEOPOROSIS INT, V17, P297, DOI 10.1007/s00198-005-2019-9-
dc.description.citedreferenceYANG S, 2006, NORMATIVE STUDY BONE-
dc.description.citedreferenceCauley JA, 2005, OSTEOPOROSIS INT, V16, P1525, DOI 10.1007/s00198-005-1866-8-
dc.description.citedreferenceCheng WM, 2005, CHINESE CHEM LETT, V16, P1481-
dc.description.citedreferenceKanis JA, 2005, OSTEOPOROSIS INT, V16, P737, DOI 10.1007/s00198-004-1734-y-
dc.description.citedreferenceKung AWC, 2005, OSTEOPOROSIS INT, V16, P849, DOI 10.1007/s00198-004-1778-z-
dc.description.citedreferenceVu TTH, 2005, AM J EPIDEMIOL, V161, P824, DOI 10.1093/aje/kwi105-
dc.description.citedreferenceShin C, 2004, J HUM HYPERTENS, V18, P717, DOI 10.1038/sj.jhh.1001732-
dc.description.citedreferenceWu XP, 2004, J BONE MINER METAB, V22, P382, DOI 10.1007/s00774-004-0499-x-
dc.description.citedreferenceGjesdal CG, 2004, OSTEOPOROSIS INT, V15, P525, DOI 10.1007/s00198-003-1573-2-
dc.description.citedreferenceYang TS, 2004, OSTEOPOROSIS INT, V15, P345, DOI 10.1007/s00198-003-1509-x-
dc.description.citedreferenceLeib ES, 2004, J CLIN DENSITOM, V7, P1-
dc.description.citedreferencePedrazzoni M, 2003, OSTEOPOROSIS INT, V14, P978, DOI 10.1007/s00198-003-1521-1-
dc.description.citedreferenceWu XP, 2003, CALCIFIED TISSUE INT, V73, P122, DOI 10.1007/s00223-002-1069-7-
dc.description.citedreferenceGur A, 2003, J BONE MINER METAB, V21, P234, DOI 10.1007/s00774-003-0415-9-
dc.description.citedreferenceKanis JA, 2002, LANCET, V359, P1929-
dc.description.citedreferenceLu Y, 2001, OSTEOPOROSIS INT, V12, P438-
dc.description.citedreferenceIki M, 2001, OSTEOPOROSIS INT, V12, P529-
dc.description.citedreferenceLunt M, 2001, OSTEOPOROSIS INT, V12, P688, DOI 10.1007/s001980170069-
dc.description.citedreferenceAHAMD OBP, 2001, AGE STANDARDIZATION-
dc.description.citedreference*KOR NAT STAT OFF, 2001, STAT KOR-
dc.description.citedreferenceLofman O, 2000, J CLIN DENSITOM, V3, P177-
dc.description.citedreferenceTenenhouse A, 2000, OSTEOPOROSIS INT, V11, P897-
dc.description.citedreferenceOrwoll ES, 2000, OSTEOPOROSIS INT, V11, P815-
dc.description.citedreferenceVarenna M, 1999, OSTEOPOROSIS INT, V9, P236-
dc.description.citedreferenceLooker AC, 1997, J BONE MINER RES, V12, P1761-
dc.description.citedreferenceGullberg B, 1997, OSTEOPOROSIS INT, V7, P407-
dc.description.citedreferenceMarshall D, 1996, BRIT MED J, V312, P1254-
dc.description.citedreferenceOrwoll ES, 1996, ANN INTERN MED, V124, P187-
dc.description.citedreferenceLOOKER AC, 1995, OSTEOPOROSIS INT, V5, P389-
dc.description.citedreference1994, WHO TECH REP SER, V843, P1-
dc.description.tc5-
Appears in Collections:
Files in This Item:
There are no files associated with this item.

Altmetrics

Item View & Download Count

  • mendeley

Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.

Share